Indeed, we observed that overexpression of NRF2 in tRCC cells impaired proliferation, although it enhanced the proliferation of highly glycolytic ccRCC cells (Extended Data Fig. 4a–b). The gene discussed is NFE2L2; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.